Results 151 to 160 of about 3,123 (163)

Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna

Clinical Infectious Diseases, 2018
Florian Thalhammer, Heinz Burgmann, Stefan Winkler   +2 more
exaly  

New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection.

Antimicrobial Agents and Chemotherapy, 2020
Antonio Zizzi, Annamaria Offidani, Fiorenza Orlando   +2 more
exaly  

activity of dalbavancin against biofilms of staphylococci isolated from prosthetic joint infections

Diagnostic Microbiology and Infectious Disease, 2016
Javier Fernández, Kerryl E Greenwood-Quaintance   +1 more
exaly  

Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci

Diagnostic Microbiology and Infectious Disease, 2018
Suzannah M Schmidt-Malan
exaly  

Emergence of dalbavancin non-susceptible, vancomycin-intermediate Staphylococcus aureus (VISA) after treatment of MRSA central line-associated bloodstream infection with a dalbavancin- and vancomycin-containing regimen

Clinical Microbiology and Infection, 2018
Brian Werth, Tim Weaver
exaly  

Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin

Journal of Clinical Pharmacy and Therapeutics, 2018
J M Steele
exaly  

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety.

Open Forum Infectious Diseases, 2019
Michael Dunne, David Melnick, Alena Jandourek   +2 more
exaly  

Epithelial Lining Fluid and Plasma Concentrations of Dalbavancin in Healthy Adults after a Single 1,500-Milligram Infusion.

Antimicrobial Agents and Chemotherapy, 2019
Michael Dunne, Sailaja Puttagunta
exaly  

Treatment of osteoarticular, cardiovascular, intravascular-catheter-related and other complicated infections with dalbavancin and oritavancin: A systematic review

International Journal of Antimicrobial Agents, 2020
Andrés F Henao-Martínez, Daniel B Chastain   +1 more
exaly  

Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population

Open Forum Infectious Diseases, 2019
Shireesha Dhanireddy, Alison M Beieler, Chloe Bryson-Cahn   +2 more
exaly